S-(-)-Carbidopa, >=98% (TLC), powder

Code: C1335-25MG D2-231

Biochem/physiol Actions

Peripheral inhibitor of L-aromatic amino acid decarboxylase. When co-administered with L-DOPA, it prevents extra-CNS conversion to dopamine, thereby i...


 Read more

Your Price
€114.91 25MG
€141.34 inc. VAT
REQUEST

Biochem/physiol Actions

Peripheral inhibitor of L-aromatic amino acid decarboxylase. When co-administered with L-DOPA, it prevents extra-CNS conversion to dopamine, thereby increasing CNS concentrations of effective compounds. Selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells by increasing H2O2 in these cell lines, which are sensitive to reactive oxygen species.

General description

Carbidopa is used for treating restless legs (RL) syndrome and periodic leg movements in sleep (PLMS). Carbidopa along with levodopa is used to treat Parkinson′s disease.

Packaging

100 mg in glass bottle

25 mg in poly bottle

assay≥98% (TLC)
formpowder
Gene Informationhuman ... DDC(1644)
InChI keyTZFNLOMSOLWIDK-JTQLQIEISA-N
InChI1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1
Quality Level200
SMILES stringCC(Cc1ccc(O)c(O)c1)(NN)C(O)=O
solubilitymethanol and 1 drop HCl: 4.90-5.10 mg/mL, clear, colorless to faintly yellow
storage temp.−20°C
Cas Number28860-95-9
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.